Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 2004

Study Completion Date

September 30, 2005

Conditions

Atopic Dermatitis

Interventions

DRUG

Pimecrolimus

Pimecrolimus cream 1 % applied twice daily (b.i.d.)

DRUG

Pimecrolimus

Pimecrolimus cream 1 % applied once daily (o.d.) and placebo applied once daily (o.d.)

Trial Locations (1)

This study is not being conducted in the United States, Novartis Pharma AG